Bain Capital Life Sciences Investors’s Nuvalent NUVL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,447,267	Closed	-$110M	–	24
2025 Q2	$110M	Hold	1,447,267	–	–	13.82%	3
2025 Q1	$103M	Hold	1,447,267	–	–	15.19%	2
2024 Q4	$113M	Sell	1,447,267 -1,250,000	-46%	-$117M	13.33%	2
2024 Q3	$276M	Hold	2,697,267	–	–	28.71%	1
2024 Q2	$205M	Hold	2,697,267	–	–	22.46%	1
2024 Q1	$203M	Sell	2,697,267 -880,000	-25%	-$70M	16.28%	2
2023 Q4	$263M	Hold	3,577,267	–	–	25.23%	1
2023 Q3	$164M	Hold	3,577,267	–	–	18.39%	1
2023 Q2	$151M	Hold	3,577,267	–	–	15.54%	1
2023 Q1	$93.3M	Hold	3,577,267	–	–	11.66%	2
2022 Q4	$107M	Buy	3,577,267 +149,253	+4%	+$4.16M	11.9%	2
2022 Q3	$66.6M	Hold	3,428,014	–	–	7.95%	2
2022 Q2	$46.5M	Hold	3,428,014	–	–	5.45%	6
2022 Q1	$47.6M	Hold	3,428,014	–	–	4.62%	6
2021 Q4	$65.3M	Hold	3,428,014	–	–	5.18%	6
2021 Q3	$77.3M	Buy	+3,428,014	New	+$99.5M	4.8%	7